CAS 1453028-33-5

3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel-

Description:

3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel- is a complex organic compound characterized by its bicyclic structure, which includes a diazabicyclo framework. This compound features multiple functional groups, including imidazole and pyrazole moieties, which contribute to its potential biological activity. The presence of these heterocycles suggests that it may exhibit interesting pharmacological properties, possibly acting as a ligand or inhibitor in various biochemical pathways. The stereochemistry indicated by the (1R,5S)- designation implies specific spatial arrangements of atoms, which can significantly influence the compound's reactivity and interactions with biological targets. Additionally, the compound's solubility, stability, and reactivity will depend on its molecular structure and the nature of its substituents. Overall, this compound represents a class of molecules that may have applications in medicinal chemistry and drug development, warranting further investigation into its properties and potential uses.

Formula: C₂₀H₂₆N₆O

Synonyms:

• DRP1i27
• 3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel-

DRP1i27

CAS: 1453028-33-5

DRP1i27 inhibits human Drp1 at GTPase site, prevents mitochondrial fission, and shields cells from ischemia-reperfusion damage.

Formula: C₂₀H₂₆N₆O

Color and Shape: Solid

Molecular weight: 366.46

Ref: TM-T73456